Literature DB >> 20627243

Reproductive characteristics and risk of uterine leiomyomata.

Kathryn L Terry1, Immaculata De Vivo, Susan E Hankinson, Stacey A Missmer.   

Abstract

OBJECTIVE: To evaluate whether menstrual and reproductive characteristics may influence development of uterine leiomyomata since sex steroid hormones have been hypothesized to play a role in their development.
DESIGN: A prospective cohort study (Nurses' Health Study II).
SETTING: Participants were identified from 14 states and followed for 14 years. PATIENT(S): A cohort of 116,609 female registered nurses ages 25-42 at baseline. INTERVENTION(S): We obtained data on uterine leiomyomata incidence and exposures through biennial questionnaires. We calculated hazard ratios and 95% confidence intervals adjusted for known and suspected risk factors. MAIN OUTCOME MEASURE(S): Uterine leiomyomata confirmed by ultrasound or hysterectomy. RESULT(S): During 1,163,439 person-years of follow-up, 9,847 self-reported cases of hysterectomy- or ultrasound-confirmed uterine leiomyomata were reported. We observed a lower incidence of uterine leiomyomata with later age at menarche, longer menstrual cycles, parity, later age at first and last birth, shorter time since last birth, and breastfeeding. CONCLUSION(S): Hormonal and anatomical changes associated with menstruation and pregnancy may influence uterine leiomyomata incidence.
Copyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20627243      PMCID: PMC2956020          DOI: 10.1016/j.fertnstert.2010.04.065

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  19 in total

1.  Hysterectomy rates in the United States 1990-1997.

Authors:  Cynthia M Farquhar; Claudia A Steiner
Journal:  Obstet Gynecol       Date:  2002-02       Impact factor: 7.661

Review 2.  Uterine fibroids.

Authors:  E A Stewart
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

3.  Hospitalization costs associated with leiomyoma.

Authors:  S Z Zhao; J M Wong; L M Arguelles
Journal:  Clin Ther       Date:  1999-03       Impact factor: 3.393

4.  Variation in the incidence of uterine leiomyoma among premenopausal women by age and race.

Authors:  L M Marshall; D Spiegelman; R L Barbieri; M B Goldman; J E Manson; G A Colditz; W C Willett; D J Hunter
Journal:  Obstet Gynecol       Date:  1997-12       Impact factor: 7.661

Review 5.  Epidemiologic contributions to understanding the etiology of uterine leiomyomata.

Authors:  S M Schwartz; L M Marshall; D D Baird
Journal:  Environ Health Perspect       Date:  2000-10       Impact factor: 9.031

Review 6.  Advances in uterine leiomyoma research: conference overview, summary, and future research recommendations.

Authors:  R R Newbold; R P DiAugustine; J I Risinger; J I Everitt; D K Walmer; E C Parrott; D Dixon
Journal:  Environ Health Perspect       Date:  2000-10       Impact factor: 9.031

7.  Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case--control study.

Authors:  P Lumbiganon; S Rugpao; S Phandhu-fung; M Laopaiboon; N Vudhikamraksa; Y Werawatakul
Journal:  Br J Obstet Gynaecol       Date:  1996-09

8.  New concepts in the treatment of uterine leiomyomas.

Authors:  E A Stewart; R A Nowak
Journal:  Obstet Gynecol       Date:  1998-10       Impact factor: 7.661

9.  Reproductive factors and risk of uterine fibroids.

Authors:  F Parazzini; E Negri; C La Vecchia; L Chatenoud; E Ricci; P Guarnerio
Journal:  Epidemiology       Date:  1996-07       Impact factor: 4.822

10.  A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata.

Authors:  L M Marshall; D Spiegelman; M B Goldman; J E Manson; G A Colditz; R L Barbieri; M J Stampfer; D J Hunter
Journal:  Fertil Steril       Date:  1998-09       Impact factor: 7.329

View more
  14 in total

Review 1.  Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

Authors:  Arno E Commandeur; Aaron K Styer; Jose M Teixeira
Journal:  Hum Reprod Update       Date:  2015-07-03       Impact factor: 15.610

2.  Hyperplasia and fibrosis in mice with conditional loss of the TSC2 tumor suppressor in Müllerian duct mesenchyme-derived myometria.

Authors:  Tomoko Kaneko-Tarui; Arno E Commandeur; Amanda L Patterson; Justin L DeKuiper; David Petillo; Aaron K Styer; Jose M Teixeira
Journal:  Mol Hum Reprod       Date:  2014-09-04       Impact factor: 4.025

3.  Uterine fibroid polygenic risk score (PRS) associates and predicts risk for uterine fibroid.

Authors:  Jacqueline A Piekos; Jacklyn N Hellwege; Yanfei Zhang; Eric S Torstenson; Gail P Jarvik; Ozan Dikilitas; Iftikhar J Kullo; Daniel J Schaid; David R Crosslin; Sarah A Pendergrass; Ming Ta Michael Lee; Dan Roden; Josh C Denny; Todd L Edwards; Digna R Velez Edwards
Journal:  Hum Genet       Date:  2022-02-28       Impact factor: 5.881

4.  Environmental tobacco smoke and risk of late-diagnosis incident fibroids in the Study of Women's Health across the Nation (SWAN).

Authors:  Jason Y Y Wong; Po-Yin Chang; Ellen B Gold; Wesley O Johnson; Jennifer S Lee
Journal:  Fertil Steril       Date:  2016-07-18       Impact factor: 7.329

Review 5.  Contributions of the Nurses' Health Studies to Reproductive Health Research.

Authors:  Jorge E Chavarro; Janet W Rich-Edwards; Audrey J Gaskins; Leslie V Farland; Kathryn L Terry; Cuilin Zhang; Stacey A Missmer
Journal:  Am J Public Health       Date:  2016-07-26       Impact factor: 9.308

Review 6.  Epidemiology of Uterine Fibroids: From Menarche to Menopause.

Authors:  Lauren A Wise; Shannon K Laughlin-Tommaso
Journal:  Clin Obstet Gynecol       Date:  2016-03       Impact factor: 2.190

7.  Association of age at menarche with increasing number of fibroids in a cohort of women who underwent standardized ultrasound assessment.

Authors:  Digna R Velez Edwards; Donna D Baird; Katherine E Hartmann
Journal:  Am J Epidemiol       Date:  2013-06-30       Impact factor: 4.897

8.  Circulating Sex Hormones and Risk of Uterine Fibroids: Study of Women's Health Across the Nation (SWAN).

Authors:  Jason Y Y Wong; Ellen B Gold; Wesley O Johnson; Jennifer S Lee
Journal:  J Clin Endocrinol Metab       Date:  2015-12-15       Impact factor: 5.958

9.  Association of intrauterine and early life factors with uterine leiomyomata in black women.

Authors:  Lauren A Wise; Rose G Radin; Julie R Palmer; Lynn Rosenberg
Journal:  Ann Epidemiol       Date:  2012-10-23       Impact factor: 3.797

Review 10.  Epidemiology of Uterine Myomas: A Review.

Authors:  Radmila Sparic; Ljiljana Mirkovic; Antonio Malvasi; Andrea Tinelli
Journal:  Int J Fertil Steril       Date:  2015-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.